Pfizer to ask FDA for emergency use of its COVID-19 vaccine in U.S.
FDA approval could result in vaccine doses becoming ready as early as December
Pharmaceutical company Pfizer said Friday it is asking federal regulators to allow emergency use of its COVID-19 vaccine.
Pfizer will make the request days after saying the company and German partner BioNTech's vaccine appeared to be 95% effective at the virus in late-stage clinical trials, according to the Associated Press.
The Food and Drug Administration can sometimes grant emergency-use authorization, before the final testing is fully complete.
News, Not Noise
- YouTube suspends Real America's Voice for interview in which Trump says, ‘I never admitted defeat’
- The honeymoon is over for Biden as approval numbers drop, disapproval numbers spike
- 'No business doing that': Wis. official says Zuckerberg-funded group seized control of 2020 election
- 'Horrendous': Ga. audit lawyer demands full investigation into Fulton County's ballot irregularities
- Indiana University students compare COVID vaccine mandate to Tuskegee experiment in lawsuit